Company Profile
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Latest News
Coinbase CEO Brian Armstrong Says Pivot From Crypto To AI Is 'Zero Sum, Scarcity Thinking'
'Good energy' at Chelsea as Alonso kickstarts reign in Sydney
What To Expect From Acadia Healthcare’s (ACHC) Q2 Earnings
Invitation to presentation of InstallatørGruppen's Q2 2026 Financial Report
Rio Tinto and WA Government sign agreements with Yindjibarndi WaterCo for proposed sale of Dampier Seawater Desalination Plant
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Website | https://www.lonza.com |
| Audit Risk | 3 |
| Board Risk | 1 |
| Overall Risk | 1 |
| Market Cap | 38.27B |
| Trailing P/E | 35.33 |
| Forward P/E | 25.03 |
| Dividend Rate | 5 |
| Dividend Yield | 0.91% |
| Trailing Annual Div. Rate | 5 |
| Trailing Annual Div. Yield | 0.92% |
| Trailing EPS | 15.51 |
| Forward EPS | 21.9 |
| Book Value | 116.37 |
| Price-to-Book | 4.71 |
| Enterprise-to-Revenue | 6.11 |
| Enterprise-to-EBITDA | 17.55 |
| Ex-Dividend Date | 05/12/2026 |
| Dividend Date | 05/15/2025 |
| Earnings Date | |
| Earnings Call Date | 07/22/2026 |